Brief: Enveric Biosciences Receives Notice Of Allowance From U.S. Patent & Trademark Office For Patent Application Of Evm301 Series Of Molecules
05/06/2023 16:03
June 5 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES INC - RECEIVED A NOTICE OF ALLOWANCE
FROM
U.S. PATENT & TRADEMARK OFFICE FOR PATENT APPLICATION OF EVM301
SERIES OF MOLECULES
Source text for Eikon: ID:nBw5Mtly6a
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003